Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[C-11]-CS1P1 PET in CNS Malignancies
NCT07462507Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2026
- Primary completion
- Jun 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [11C]CS1P1 in central nervous system cancer, brain metastases, sponsored by Washington University School of Medicine. Started Apr 2026; status: recruiting.
02
Drugs
[11C]CS1P1
03
Conditions
central nervous system cancerbrain metastases
Beyond the preview
Go deeper on NCT07462507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07462507.